Institut Salah Azaiz
About Institut Salah Azaiz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Millennium Pharmaceuticals, Inc.
1
National Cancer Institute (NCI)
1
Clinical Trials at Institut Salah Azaiz
During the past decade, Institut Salah Azaiz conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma
2008-05-01
2017-06-17
Completed
487
Case-Control Study of Inflammatory Breast Cancer in North Africa
2008-11-17
2018-09-30
Completed
815
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Salah Azaiz"
#1 collaborator was "Johnson & Johnson Pharmaceutical Research & Development, L.L.C." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Institut Salah Azaiz
According to Clinical.Site data, the most researched conditions in "Institut Salah Azaiz" are
"Diabetes" (1 trials) and "Mantle Cell Lymphoma" (1 trials). Many other conditions were trialed in "Institut Salah Azaiz" in a lesser frequency.
Clinical Trials Intervention Types at Institut Salah Azaiz
Most popular intervention types in "Institut Salah Azaiz" are "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide 750 mg/m^2" (1 trials), "Doxorubicin 50 mg/m^2" (1 trials), "Prednisone 100 mg/m^2" (1 trials), "Rituximab 375 mg/m^2" (1 trials) and "VELCADE 1.3 mg/m^2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institut Salah Azaiz
The vast majority of trials in "Institut Salah Azaiz" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Institut Salah Azaiz
Currently, there are NaN active trials in "Institut Salah Azaiz".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Institut Salah Azaiz,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Salah Azaiz, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".